The relevance of angiogenesis in benign and malignant epithelial tumors of the ovary: A quantitative histologic study

被引:29
作者
Brustmann, H [1 ]
Riss, P [1 ]
Naude, S [1 ]
机构
[1] LANDESKRANKENHAUS,DEPT OBSTET & GYNECOL,A-2340 MOEDLING,VIENNA,AUSTRIA
关键词
D O I
10.1006/gyno.1997.4815
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The ability of a tumor to grow and eventually to infiltrate adjacent tissues requires a sufficient blood supply. Many malignant neoplasms have been shown to induce neovascularization. We asked whether it is possible to characterize ovarian epithelial tumors on the basis of vascularization and whether vascularization can be used to differentiate between benign and malignant neoplasms. We examined 14 cases of benign cystadenomas and 18 carcinomas. The microvessels were identified by immunohistochemical staining of endothelial cells for factor VIII. They were counted within the most vascular area of a tumor (neovascular ''hot spot'') on a x100 and a x400 field. Mean vessel counts were 51.64 [standard error of the mean (SEM), 5.7] in the benign cystadenomas and 131.05 (SEM, 6.7) in the group of carcinomas at a x100 magnification. The mean microvessel counts per x400 field were 14.4 (SEM, 1.9) in the benign and 33.7 (SEM, 3.45) in the malignant tumors investigated. These differences were significant (t test for independent samples, P < 0.001). Since our study shows significantly fewer small blood vessels in the benign cystadenomas than in the malignant tumors, the histologically determinable vascular density may be the basis for imaging blood flow by means of color ultrasound. (C) 1997 Academic Press.
引用
收藏
页码:20 / 26
页数:7
相关论文
共 31 条
[1]   IMMUNOREACTIVE FIBROBLAST GROWTH-FACTOR IN CELLS OF PERITONEAL-EXUDATE SUGGESTS ITS IDENTITY WITH MACROPHAGE-DERIVED GROWTH-FACTOR [J].
BAIRD, A ;
MORMEDE, P ;
BOHLEN, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 126 (01) :358-364
[2]   COMPARISON OF MICROSCOPIC VASCULARITY IN BENIGN AND MALIGNANT PROSTATE TISSUE [J].
BIGLER, SA ;
DEERING, RE ;
BRAWER, MK .
HUMAN PATHOLOGY, 1993, 24 (02) :220-226
[3]   TUMOR INTERACTIONS WITH THE VASCULATURE - ANGIOGENESIS AND TUMOR-METASTASIS [J].
BLOOD, CH ;
ZETTER, BR .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1032 (01) :89-118
[4]   INDUCTION OF ANGIOGENESIS DURING THE TRANSITION FROM HYPERPLASIA TO NEOPLASIA [J].
FOLKMAN, J ;
WATSON, K ;
INGBER, D ;
HANAHAN, D .
NATURE, 1989, 339 (6219) :58-61
[5]   ANGIOGENIC FACTORS [J].
FOLKMAN, J ;
KLAGSBRUN, M .
SCIENCE, 1987, 235 (4787) :442-447
[6]  
FOLKMAN J, 1988, AM J PATHOL, V133, P419
[7]  
FOLKMAN J, 1992, CANC MED, P153
[8]   TUMOR-NECROSIS-FACTOR TYPE-ALPHA, A POTENT INHIBITOR OF ENDOTHELIAL-CELL GROWTH-INVITRO, IS ANGIOGENIC INVIVO [J].
FRATERSCHRODER, M ;
RISAU, W ;
HALLMANN, R ;
GAUTSCHI, P ;
BOHLEN, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (15) :5277-5281
[9]   PURIFIED MONOCYTE-DERIVED ANGIOGENIC SUBSTANCE (ANGIOTROPIN) INDUCES CONTROLLED ANGIOGENESIS ASSOCIATED WITH REGULATED TISSUE PROLIFERATION IN RABBIT SKIN [J].
HOCKEL, M ;
JUNG, W ;
VAUPEL, P ;
RABES, H ;
KHALEDPOUR, C ;
WISSLER, JH .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (03) :1075-1090
[10]  
HOLLINGSWORTH HC, 1995, AM J PATHOL, V147, P33